story of the week
Endocrine Therapy Response and 21-Gene Expression Assay to Guide Therapy in HR+/HER2– Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer
J. Clin. Oncol 2022 Aug 10;40(23)2557-2567, UA Nitz, O Gluz, S Kümmel, M Christgen, M Braun, B Aktas, K Lüdtke-Heckenkamp, H Forstbauer, EM Grischke, C Schumacher, M Darsow, K Krauss, B Nuding, M Thill, J Potenberg, C Uleer, M Warm, HH Fischer, W Malter, M Hauptmann, RE Kates, M Gräser, R Würstlein, S Shak, F Baehner, HH Kreipe, N HarbeckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.